Cargando…
Pathophysiology of NASH in endocrine diseases
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the industrialized world. NAFLD encompasses a whole spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. The latter can lead to hepatocellular carcinoma. Furthermore,...
Autores principales: | Gariani, Karim, Jornayvaz, François R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983516/ https://www.ncbi.nlm.nih.gov/pubmed/33449917 http://dx.doi.org/10.1530/EC-20-0490 |
Ejemplares similares
-
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
por: Nascè, Alberto, et al.
Publicado: (2022) -
NAFLD: From Mechanisms to Therapeutic Approaches
por: Gariani, Karim, et al.
Publicado: (2022) -
Systematic Review and Meta-Analysis of the Usefulness of Epicardial Fat Thickness as a Non-Invasive Marker of the Presence and Severity of Nonalcoholic Fatty Liver Disease
por: Orci, Lorenzo A., et al.
Publicado: (2022) -
Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report
por: Jornayvaz, François R., et al.
Publicado: (2020) -
Increased FGF21 plasma levels in humans with sepsis and SIRS
por: Gariani, Karim, et al.
Publicado: (2013)